Epigenetic Alterations in Pancreatic Cancer

Journal Title: Pancreas – Open Journal - Year 2016, Vol 1, Issue 2

Abstract

Pancreatic cancer is the fourth leading cause of cancer death and is predicted to be the second leading cause in a decade in the US. Despite more than 50 years of research and therapeutic development, pancreatic cancer still has a median survival rate of 6 months and a 5-year overall survival around 5%. Therefore, there is an urgent need to better understand the mechanism of pancreatic cancer development, as well as to discover new biomarkers for early diagnosis, prognosis, and therapeutic targets.

Authors and Affiliations

Jiaqi Shi

Keywords

Related Articles

Nutritional Support of Patients With the Abdominal Compartment Syndrome During Severe Acute Pancreatitis

There is growing evidence in the literature that development of Abdominal Compartment Syndrome (ACS) in patients with Severe Acute Pancreatitis (SAP) has a strong impact on the course of disease. Incidence of ACS in pati...

Eus-Pancreaticogastrostomy in a Patient with Subtotal Gastrectomy and Roux-En-Y Reconstruction

Chronic Pancreatitis (CP) is often associated with pain due to pancreatic duct obstruction. In these patients, surgical drainage was more effective than endoscopic treatment, achieving a faster, effective, and sustained...

Evaluation of the Best Power Setting of Laser Waves in Pancreatic Surgery: ECHO ND-YAG Laser Ablation on Bovine Pancreatic Tissue

Background: Pancreatic surgery is one of the most difficult and life-threatening surgical therapy especially during necrotizing pancreatitis and advanced solid neoplasms. Aim of the study: To evaluate the possibility to...

Recurrent Acute Pancreatitis: Dangerous Etiology?

Acute pancreatitis (AP) is a disorder clinically characterized by upper abdominal pain and elevated levels of pancreatic enzymes in the blood.1 After an initial evaluation, up to 10-30% of patients with AP are diagnosed...

Delayed Onset Post-ERCP Pancreatitis (DOPE-P)

Post Endoscopic retrograde cholangiopancreatography (ERCP) Pancreatitis (PEP) is defined as new onset or worsening of pain abdomen after ERCP with an elevation of pancreatic enzymes (amylase/lipase) more than 3 times upp...

Download PDF file
  • EP ID EP556665
  • DOI 10.17140/POJ-1-e002
  • Views 191
  • Downloads 0

How To Cite

Jiaqi Shi (2016). Epigenetic Alterations in Pancreatic Cancer. Pancreas – Open Journal, 1(2), 5-7. https://europub.co.uk/articles/-A-556665